N

NeuBase Therapeutics, Inc.

24 employees

NeuBase Therapeutics develops gene silencing therapies with its synthetic antisense oligonucleotides.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Antisense Oligonucleotide Therapies
Huntington's Disease
Genetic Disease
Myotonic Dystrophy
Therapeutics
Gene Silencing
Medical
gene editing
CNS Disease
Rare Disease

Date founded

2018

FAQ